As of 30 Sep 2025, 2 institutional investors reported holding 203,087 shares of NEW YORK LIFE INVESTMENTS ET - NYLI US LC R&D L (LRND).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 203,087 | $8,081,257 | -$137,036 | $39.79 | 2 |
| 2025 Q2 | 206,549 | $7,454,512 | -$77,164 | $36.09 | 5 |
| 2025 Q1 | 208,832 | $6,713,721 | +$58,962 | $32.15 | 4 |
| 2024 Q4 | 206,998 | $7,066,781 | +$275,251 | $34.14 | 3 |
| 2024 Q3 | 198,937 | $6,623,607 | +$30,398 | $33.30 | 3 |
| 2024 Q2 | 198,024 | $6,486,569 | -$92,017 | $32.76 | 2 |
| 2024 Q1 | 201,283 | $6,330,351 | -$242,534 | $31.45 | 3 |
| 2023 Q4 | 211,080 | $5,981,719 | +$597,357 | $28.29 | 4 |
| 2023 Q3 | 190,001 | $4,774,459 | -$771 | $25.06 | 2 |
| 2023 Q2 | 190,031 | $4,887,350 | +$797 | $25.72 | 3 |
| 2023 Q1 | 190,000 | $4,361,336 | $0 | $22.95 | 1 |
| 2022 Q4 | 190,000 | $3,787,498 | $0 | $19.93 | 1 |
| 2022 Q3 | 190,000 | $3,648,000 | $0 | $19.20 | 1 |
| 2022 Q2 | 190,000 | $190,000 | -$4,781,996 | $1.00 | 1 |
| 2022 Q1 | 380,000 | $9,564,000 | +$9,563,992 | $25.17 | 2 |